amorchem header logo close button Menu

At AmorChem we believe in the power of collaboration to help us transform biotech start ups into next gen companies

amorchem slideshow amorchem slideshow amorchem slideshow amorchem slideshow amorchem slideshow amorchem slideshow amorchem slideshow

Since 2011 we have taken great care in fostering a community made up of passionate academics, students, technology transfer officers, entrepreneurs and venture investors in order to help us achieve our collective goal: generating sustainable health and wealth via a thriving life sciences ecosystem.

amorchem logo outline

Featured Investments


A project that will focus on the identification of small molecules to treat small cell carcinoma of the ovary, hypercalcemic type (“SCCOHT”)

Learn more

Neurasic Therapeutics Inc

Neurasic’s potential drug therapy targets acid-sensing ion channels (ASICs), a gene family of neuronal receptors that play a role in multiple neurological disorders

Learn more


A program focused on developing and testing a gene therapy construct that may ultimately improve the well-being of patients with a disabling disorder by treating retinal degeneration

Learn more

ATP Synthase

Developing bacterial ATP synthase inhibitors as novel broad-spectrum antibiotics

Learn more


A novel RNA-modifying target that functions as an immune checkpoint in CNS disorders

Learn more

RNA Zipcodes

Allowing for the delivery of nucleic acid therapeutics to the appropriate subcellular localization

Learn more

MyX Thera Inc.

Designing an innovative delivery platform for novel product formulations

Learn more

Inversago Pharma Inc

Pioneering the comeback of CB1 inverse agonists.

Learn more
Semathera Inc.

SemaThera Inc.

Novel inhibitors of semaphorin 3A for the prevention and reversal of retinal vascular diseases

Learn more
Corbin Therapeutics Inc.

Corbin Therapeutics Inc.

Exploiting USP15 inhibition as a key mechanism to protect against neuroinflammation

Learn more


GvHD Diagnostic
Greater trochanter Fixation device
CD73 Immuno-oncology
CD36 CV Now Mperia
TALENs Friedreich’s ataxia
SEMA3A Now SemaThera
CFTR Acquired by Vertex
Chemogenomics AML prognostic
GAG AL Amyloidosis
17BHSD1 Oncology
USP15 Now Corbin
IGF-1 Trap Oncology
Urotensin Pulmonary Arterial Hypertension
MiHa Now SpecificiT
S100A9 Under option
RNA foci Myotonic Dystrophy
OXO ETE Now Fairhaven
ABHD6 Diabetes
DNMTI Oncology
CD36 AMD Now Mperia
Porous Titanium Screw Fixation device
PSCK9 SD Hypercholesterolemia
PCSK9 SM Hypercholesterolemia